Pragmatism and PSA

BJU International

Volumn 92, Issue 4, 2003, Pages 340-341

  Moffat, L E F ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE; ANTINEOPLASTIC AGENT; HORMONE; PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;

ANTIGEN DETECTION; CANCER DIAGNOSIS; CANCER HORMONE THERAPY; CANCER MORTALITY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER RISK; CANCER SCREENING; CANCER SURVIVAL; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CLINICAL FEATURE; CLINICAL TRIAL; DISEASE MARKER; HUMAN; IMPOTENCE; NOTE; ORCHIECTOMY; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATECTOMY; SIDE EFFECT;

AGED; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RANDOMIZED CONTROLLED TRIALS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0041408884     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.2003.04366.x     Document Type: Note

References (11)

1. Ablin RJ, Soanes WA, Bronson P, Witebsky E. Precipitating antigens of the normal human prostate. J Reprod Fertil 1970; 22: 573-4
2. Carter HB, Partin AW. Diagnosis and staging of prostate cancer. In Walsh PC, Retik AB, Vaughn ED, Wein AJ eds, Campbell's Urology, 8th edn. Philadelphia: WB Saunders, 2002
3. Moffat LEF. Urological Cancer - a Practical Guide. London: Martin Dunitz, 2002
4. Lu-Yao GL, Yao SL. Population based study of long-term survival in patients with clinically localised prostate cancer. Lancet 1997; 349: 906-10
5. Albertsen PC, Hanley JA, Gleason DF, Barry MJ. Competing risk analysis of men aged 55-74 years at diagnosis managed conservatively for clinically localized prostate cancer. JAMA 1998; 280: 975-80
6. Holmberg L, Bill-Axelson A, Helgesen F et al. A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer. N Engl J Med 2002; 347: 781-9
7. Kirby RS, Fitzpatrick JM. Radical prostatectomy or watchful waiting. BJU Int 2003; 91: 5
8. Senn S. Statistical Issues in Drug Development. London: John Wiley and Sons, 1997
9. http//:http://www.gad.gov.uk/Life_Tables/docs/wltukm9901.xls
10. Potosky AL, Legler J, Albertsen PC et al. Health outcomes after prostatectomy or radiotherapy for prostate cancer: results from the Prostate Cancer Outcomes Study. J Natl Cancer Inst 2000; 92: 1582-92
11. Chapman S. Fresh row over prostate screening. Br Med J 2003; 326: 605